Clinical Trials Directory

Trials / Completed

CompletedNCT06102278

ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture

Machine Learning Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture

Status
Completed
Phase
Study type
Observational
Enrollment
522 (actual)
Sponsor
Chen Xiaoping · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

This study aimed to address the issue of peritoneal metastasis (PM) following the rupture of hepatocellular carcinoma (HCC) and its adverse impact on patient prognosis. Clinical data from 522 patients with ruptured HCC who underwent surgery at seven different medical centers were collected and analyzed. Machine learning models were employed for analysis and prediction.

Conditions

Interventions

TypeNameDescription
OTHERPeritoneal MetastasisPatients experiencing postoperative peritoneal metastasis

Timeline

Start date
2020-01-01
Primary completion
2023-03-01
Completion
2023-04-01
First posted
2023-10-26
Last updated
2023-10-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06102278. Inclusion in this directory is not an endorsement.

ML Models for Predicting Postoperative Peritoneal Metastasis After Hepatocellular Carcinoma Rupture (NCT06102278) · Clinical Trials Directory